Skip to main content
Clinical Trials/NCT04293926
NCT04293926CompletedNot Applicable

Effects of a Resistance Training Program on Heart Rate Variability in Children and Adolescents With Cystic Fibrosis

Universidad Europea de Madrid2 sites in 1 country19 target enrollmentStarted: March 5, 2020Last updated:
Conditions

Trial Snapshot

Phase
Not Applicable
Status
Completed
Sponsor
Enrollment
19
Locations
2
Primary Endpoint
Change in the root mean square standard deviation (RMSSD) expressed in milliseconds (m/s)

Study Overview

Brief Summary

This study aims to assess the effects of a resistance exercise training program on heart rate variability in a group of children and adolescents with cystic fibrosis. The study design is a randomized controlled trial.

Detailed Description

A randomized controlled study will be carried out in children diagnosed with cystic fibrosis aged 6 to 18 years. Individuals will be divided into two groups: control group (CON) and strength training (ST). Heart rate variability will be analyzed using KUBIOS and measured using a Suunto watch, with subjects in lying position without movements or speaking for 5 minutes. Patients in the ST group will complete an individualized guided strength program for 8 weeks (3 sessions of 60 min/week). Training prescription will be individualized and based on the 5 repetition maximum test (60-80%). Upper and lower limbs exercises will be used, including seated bench press, seated lateral row and leg press. Outcome measures will be performed at baseline and after 8 weeks.

Study Design

Study Type
Interventional
Allocation
Randomized
Intervention Model
Parallel
Primary Purpose
Treatment
Masking
None

Eligibility Criteria

Ages
6 Years to 18 Years (Child, Adult)
Sex
All
Accepts Healthy Volunteers
No

Inclusion Criteria

  • Diagnosis of Cystic Fibrosis
  • Age between 6 and 18 years old
  • Mild to moderate lung function levels
  • Signature of the informed consent form by legal guardian and patient.

Exclusion Criteria

  • Active smoking
  • Exacerbation in the last 3 months
  • Presence of gastrostomy
  • Use of beta-blocker drugs
  • Diagnosed heart disease
  • Alterations in the locomotor system

Outcomes

Primary Outcomes

Change in the root mean square standard deviation (RMSSD) expressed in milliseconds (m/s)

Time Frame: Baseline and 8 weeks

Changes in time-domain RMSSD will be measured through heart rate variability assessment using a heart rate band and an Ambit 3 Sport watch. Variables will be collected during a five minute period.

Change in the high frequency band (HF) expressed in normalized unites (nu)

Time Frame: Baseline and 8 weeks

Changes in frequency-domain HF will be measured through heart rate variability assessment using a heart rate band and an Ambit 3 Sport watch. Variables will be collected during a five minute period.

Change in the standard deviation of R-R intervals (SDNN) expressed in milliseconds (m/s)

Time Frame: Baseline and 8 weeks

Changes in time-domain SDNN will be measured through heart rate variability assessment using a heart rate band and an Ambit 3 Sport watch. Variables will be collected during a five minute period.

Change in the percentage of differences between R-R intervals higher than 50 m/s (PNN50) expressed in percentage (%)

Time Frame: Baseline and 8 weeks

Changes in time-domain PNN50 will be measured through heart rate variability assessment using a heart rate band and an Ambit 3 Sport watch. Variables will be collected during a five minute period.

Change in the low frequency band (LF) expressed in normalized unites (nu)

Time Frame: Baseline and 8 weeks

Changes in frequency-domain LF will be measured through heart rate variability assessment using a heart rate band and an Ambit 3 Sport watch. Variables will be collected during a five minute period.

Change in the quotient (LF/HF) between the low frequency band (LF) and the high frequency band (HF) expressed as a ratio

Time Frame: Baseline and 8 weeks

Changes in frequency-domain HF will be measured through heart rate variability assessment using a heart rate band and an Ambit 3 Sport watch. Variables will be collected during a five minute period.

Secondary Outcomes

  • Change in the forced expiratory volume in one second (FEV1) expressed as z-score(Baseline and 8 weeks)
  • Change in the forced vital capacity (FVC) expressed as z-score(Baseline and 8 weeks)

Investigators

Sponsor
Universidad Europea de Madrid
Sponsor Class
Other
Responsible Party
Principal Investigator
Principal Investigator

Margarita Perez

Full Professor In Exercise Physiology, MD, PhD

Universidad Europea de Madrid

Study Sites (2)

Loading locations...

Similar Trials